Lung Cancer
Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)
- Details
ClinicalTrials.gov ID:
NCT05671510
Diagnosis Type:
NA
USOR Number:
- Address
,
P: